García-Torres R, Orozco L
Departamento de Patología, Instituto Nacional de Cardiología, México, D.F.
Bol Med Hosp Infant Mex. 1993 Aug;50(8):596-602.
The Alport's syndrome is a disease characterized by a symptomatic triad: nephropathy, hypoacusia and ocular alterations. This syndrome is genetically heterogeneous and results from numerous mutations in COL4A5 gene, whose locus resides on the long arm of the X chromosome (Xq22). This gene codifies for IV collagen alpha 5 chain, which is a fundamental constituent of the glomerular, lens and Corti's organ basal membranes. Present knowledge on molecular genetics and the characterization of the different mutations that affect the Alport's gene will lead to classification of this syndrome in subtypes, according to those mutations, and to its phenotypic expressions; in addition, some syndromes, phenotypically similar, will probably have to be distinguished from Alport's disease, in a future, if a genetic alteration is found in genes other than COL4A5.
肾病、听力减退和眼部改变。该综合征具有遗传异质性,由COL4A5基因的众多突变引起,其基因座位于X染色体长臂(Xq22)上。该基因编码IV型胶原α5链,它是肾小球、晶状体和柯蒂氏器基底膜的基本组成成分。目前关于分子遗传学的知识以及影响阿尔波特基因的不同突变的特征,将导致根据这些突变及其表型表达对该综合征进行亚型分类;此外,如果在COL4A5基因以外的其他基因中发现基因改变,未来可能需要将一些表型相似的综合征与阿尔波特病区分开来。